Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SEROTONIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | SEROTONIN |
| Key Genes/Proteins | BDNF, AKT, AMYLOID, PI3K, IL-6 |
| Related Diseases | ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, DEPRESSION, OBESITY |
| Linked Hypotheses | 1 hypotheses |
Knowledge base pages for this entity
graph TD
SEROTONIN["SEROTONIN"]
style SEROTONIN fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
SEROTONIN -.->|"protects against"| Depression["Depression"]
SEROTONIN -->|"regulates"| NEURONAL_PLASTICITY["NEURONAL PLASTICITY"]
SEROTONIN -->|"modulates"| GAPDH([GAPDH])
SEROTONIN -->|"regulates"| Neuronal_Plasticity["Neuronal Plasticity"]
SEROTONIN -->|"modulates"| SERT([SERT])
SEROTONIN -->|"involved_in"| Hippocampus_Dependent_Learning["Hippocampus-Dependent Learning"]
SEROTONIN -->|"regulates"| Neuronal_Maturation["Neuronal Maturation"]
Exercise["Exercise"] -->|"upregulates"| SEROTONIN
AADC["AADC"] -->|"catalyzes"| SEROTONIN
Tryptophan["Tryptophan"] -->|"interacts"| SEROTONIN
SSRIs{"SSRIs"} -->|"targets"| SEROTONIN
Circadian_Clock_Genes["Circadian Clock Genes"] -->|"regulates"| SEROTONIN
SERT -->|"regulates"| SEROTONIN
exercise["exercise"] -->|"activates"| SEROTONIN
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"regulates"| SEROTONIN
AMYLOID([AMYLOID]) -->|"activates"| SEROTONIN| Target | Relation | Type | Str |
|---|---|---|---|
| NEURONAL PLASTICITY | regulates | entity | 0.90 |
| DEPRESSION | associated_with | entity | 0.90 |
| ALZHEIMER'S DISEASE | associated_with | entity | 0.85 |
| NEURONS | produces | cell_type | 0.70 |
| MELATONIN | causes | drug | 0.70 |
| DEPRESSION | increases_risk | disease | 0.65 |
| HIPPOCAMPUS | produces | brain_region | 0.65 |
| OBESITY | produces | disease | 0.65 |
| FLUOXETINE | inhibits | drug | 0.65 |
| BIPOLAR DISORDER | regulates | disease | 0.65 |
| DEPRESSION | causes | disease | 0.65 |
| ALZHEIMER'S DISEASE | targets | disease | 0.65 |
| MITOPHAGY | regulates | phenotype | 0.65 |
| MITOPHAGY | interacts_with | phenotype | 0.65 |
| MITOCHONDRIAL DYSFUNCTION | exacerbates | phenotype | 0.65 |
| CORTEX | treats | brain_region | 0.65 |
| SCHIZOPHRENIA | causes | disease | 0.65 |
| HIPPOCAMPUS | causes | brain_region | 0.65 |
| HIPPOCAMPUS | inhibits | brain_region | 0.65 |
| OXIDATIVE STRESS | activates | phenotype | 0.65 |
| OXIDATIVE STRESS | inhibits | phenotype | 0.65 |
| NEUROINFLAMMATION | inhibits | phenotype | 0.65 |
| HIPPOCAMPUS | implicated_in | brain_region | 0.55 |
| OBESITY | depleted_in | disease | 0.55 |
| DOPAMINERGIC NEURONS | activates | concept | 0.50 |
| LEVODOPA | associated_with | drug | 0.50 |
| L-DOPA | associated_with | drug | 0.45 |
| CORTEX | associated_with | brain_region | 0.45 |
| SERTRALINE | associated_with | drug | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER'S DISEASE | associated_with | disease | 0.90 |
| PARKINSON'S DISEASE | associated_with | disease | 0.74 |
| BDNF | associated_with | gene | 0.74 |
| AKT | associated_with | gene | 0.66 |
| AMYLOID | associated_with | protein | 0.66 |
| PI3K | associated_with | gene | 0.66 |
| IL-6 | associated_with | gene | 0.66 |
| TAU | regulates | protein | 0.65 |
| NEURONS | causes | cell_type | 0.65 |
| ATP | inhibits | phenotype | 0.65 |
| NEUROINFLAMMATION | causes | phenotype | 0.65 |
| KYNURENINE PATHWAY | activates | pathway | 0.65 |
| TNF | associated_with | gene | 0.56 |
| NEUROGENESIS | implicated_in | phenotype | 0.55 |
| ALZHEIMER | regulates | gene | 0.50 |
| Alzheimer'S Disease | regulates | disease | 0.50 |
| ANXIETY | regulates | gene | 0.50 |
| disease | regulates | disease | 0.50 |
| ALZHEIMER'S | regulates | concept | 0.50 |
| NEURONS | associated_with | concept | 0.50 |
| AUTISM | activates | disease | 0.50 |
| DEPRESSION | activates | disease | 0.50 |
| SCHIZOPHRENIA | activates | disease | 0.50 |
| ALZHEIMER | activates | gene | 0.50 |
| Alzheimer'S Disease | activates | disease | 0.50 |
| disease | activates | disease | 0.50 |
| ALZHEIMER'S | activates | concept | 0.50 |
| DEPRESSION | associated_with | disease | 0.50 |
| aging | associated_with | phenotype | 0.50 |
| disease | associated_with | disease | 0.50 |
| DEMENTIA | associated_with | gene | 0.50 |
| HTTLPR | activates | concept | 0.50 |
| Hippocampus | activates | entity | 0.50 |
| DOPAMINE | activates | concept | 0.50 |
| Hippocampus | associated_with | entity | 0.50 |
| DOPAMINE | associated_with | concept | 0.50 |
| Neuroinflammation | regulates | process | 0.50 |
| CLOCK | regulates | gene | 0.50 |
| GABA | regulates | gene | 0.50 |
| oxidative stress | regulates | phenotype | 0.50 |
| Synaptic Plasticity | regulates | pathway | 0.50 |
| DOPAMINE | regulates | concept | 0.50 |
| acetylcholine | regulates | disease | 0.50 |
| mTOR | regulates | entity | 0.50 |
| NF-κB | regulates | concept | 0.50 |
| Chemoresistance | regulates | pathway | 0.50 |
| Neuroinflammation | activates | process | 0.50 |
| P2Y12 | activates | protein | 0.50 |
| MULTIPLE SCLEROSIS | activates | disease | 0.50 |
| EXERCISE | causes | concept | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||